Scholar Rock to Present at Upcoming Investor Conferences
Business Wire•17/11/2026•08:00 ET
0
Key Highlights
- ➤Scholar Rock to participate in Evercore Healthcare Conference fireside chat December 1, 2026
- ➤Scholar Rock to participate in Citi Global Healthcare Conference fireside chat December 2, 2026
- ➤FDA approved ISEMBYLD in September 2026 for U.S. SMA patients aged two and older
- ➤Scholar Rock plans global ISEMBYLD expansion to up to 50 countries, subject to approvals
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced that management will participate in the following investor conferences:
* 9(th) Annual Evercore Healthcare Conference: Scholar Rock is scheduled to participate in a fireside chat at 8:45 a.m. ET on Tuesday, December 1, 2026, in Miami.
Get started
Create a free account to read the full story.
